Xenap Plus 500 mg+20 mg (Tablet (Delayed Release))
Unit Price: ৳ 15.00 (3 x 10: ৳ 450.00)
Strip Price: ৳ 150.00
Medicine Details
Category | Details |
---|---|
Generic | Naproxen sodium esomeprazole magnesium |
Company | Astra biopharmaceuticals ltd |
Indications
- Relief of signs & symptoms of osteoarthritis
- Relief of signs & symptoms of rheumatoid arthritis
- Relief of signs & symptoms of ankylosing spondylitis
- Decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers
Pharmacology
- Consists of an immediate release Esomeprazole Magnesium layer & an enteric-coated Naproxen core
- Naproxen is a NSAID with analgesic & antipyretic properties
- Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion
Dosage
- Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals
- Adult dosage: one tablet twice daily of either 375 mg naproxen/20 mg of esomeprazole or 500 mg naproxen/20 mg of esomeprazole
- Adolescent dosage: based on weight, for naproxen/esomeprazole combination
Administration
- Tablet is to be taken at least 30 minutes before meals
Interaction
- Concomitant use of NSAIDs may reduce the antihypertensive effect of ACE inhibitors, diuretics & beta-blockers
- Concomitant use of this tablet and warfarin may result in an increased risk of a bleeding complication
- Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability
Contraindications
- Known hypersensitivity to any component of this tablet or substituted benzimidazoles
- History of asthmay urticaria or other allergic-type reactions after taking aspirin or other NSAIDs
- Use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
Side Effects
- Decreases the occurrence of gastric ulcers and NSAID-associated upper gastrointestinal adverse events compared to Naproxen alone
- May be associated with a small increased risk of arterial thrombotic events
- Oedema, hypertension, and cardiac failure have been reported in association with NSAID treatment
Pregnancy & Lactation
- Should not be given during the first and second trimester of pregnancy unless the potential benefit to the patient outweighs the potential risk to the foetus
- Contraindicated during the third trimester of pregnancy
- Not recommended during breastfeeding
- Use of NSAIDs like Naproxen may impair female fertility
Precautions & Warnings
- The combination of Naproxen and Esomeprazole tablet and NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided
- Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms
- Risk-factors to develop NSAID related gastro-intestinal complications include high age, concomitant use of anticoagulants, corticosteroids, other NSAIDs including low-dose acetylsalicylic acid, debilitating cardiovascular disease, Helicobacter pylori infection, and a history of gastric and/or duodenal ulcers and upper gastrointestinal bleeding
Use in Special Populations
- Adjustment of dosage may be required in elderly patients
- Not recommended for use in patients with moderate to severe or severe renal impairment
- Monitor patients with mild to moderate hepatic impairment closely & consider a possible dose reduction based on the Naproxen component of this tablet
Overdose Effects
- Symptoms include lethargy, dizziness, drowsiness, epigastric pain, abdominal discomfort, heartburn, nausea, alterations in liver function, renal dysfunction, metabolic acidosis, and vomiting
- No specific antidotes
Therapeutic Class
- Drugs for Osteoarthritis
- Drugs used for Rheumatoid Arthritis
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Storage Conditions
- Store at temperature of below 30°C
- Protect from light & moisture
- Keep out of reach of children
Related Brands
- Xenmep 500 mg+20 mg (Tablet (Delayed Release)) - ethical-drugs-limited
- Nasonaaf 500 mg+20 mg (Tablet (Delayed Release)) - naafco-pharma-ltd
- Annova Plus 500 mg+20 mg (Tablet (Delayed Release)) - beacon-pharmaceuticals-plc
- Annova Plus 375 mg+20 mg (Tablet (Delayed Release)) - beacon-pharmaceuticals-plc
- Naproqure Plus 500 mg+20 mg (Tablet (Delayed Release)) - pristine-pharmaceuticals-ltd